Ivantis Inc. in Irvine closed on a $25 million Series C funding round for development and eventual marketing of a stent intended for use in glaucoma surgery. New investor RA Capital Management LLC in ...
ZURICH, Aug 29 (Reuters) - Novartis eye care unit Alcon is voluntarily withdrawing its CyPass Micro-Stent after follow-up clinical data showed patients using the product experienced statistically ...
Glaukos Corp. in San Clemente paid $5.5 million to Dose Medical Corp. in Laguna Hills for wireless sensor technology to incorporate into Glaukos’ eye stent product line to treat glaucoma. Milestones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results